Factors affecting pharmacokinetics of benzimidazole anthelmintics in food-producing animals: The consequences and potential risks

Research in Veterinary Science

Volumn 91, Issue 3, 2011, Pages 333-341

  Krizova Forstova V ^a   Lamka, J ^a   Cvilink, V ^a   Hanusova V ^a   Skalova L ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Anthelmintics bioavailability; Anthelmintics efficacy; Anthelmintics metabolism; Benzimidazoles; Sex differences; Species differences

Indexed keywords

BENZIMIDAZOLE; TRICLABENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; AREA UNDER THE CURVE; CATTLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TRANSFORMATION; ENVIRONMENTAL FACTOR; FEMALE; HELMINTHIASIS; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; REVIEW; SHEEP; SPECIES DIFFERENCE;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG RESIDUES; FOOD ANALYSIS; RISK FACTORS; SPECIES SPECIFICITY;

ANIMALIA;

EID: 80052327584     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.12.013     Document Type: Review

References (102)

1. Ali D.N., Hennessy D.R. The effect of feed intake on the rate of flow of digest and the disposition and activity of oxfendazole in sheep. International Journal for Parasitology 1993, 23:477-484.
2. Ali D.N., Hennessy D.R. The effect of level of feed intake on the pharmacokinetic disposition of oxfendazole in sheep. International Journal for Parasitology 1995, 25:63-70.
3. Ali D.N., Hennessy D.R. The effect of reduced feed intake on the efficacy of oxfendazole against benzimidazole resistant Haemonchus contortus and Trichostrongylus columbriformis in sheep. International Journal for Parasitology 1995, 25:71-74.
4. Ali D.N., Hennessy D.R. The effect of level feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep. Journal of Veterinary Pharmacology and Therapeutics 1996, 19:89-94.
5. Alvarez L.I., Saumell C.A., Sanchez S.F., Lanusse C.E. Plasma disposition kinetics of albendazole metabolites in pigs fed different diets. Research in Veterinary Science 1996, 60:152-156.
6. Alvarez L.I., Sfincher S.F., Lanusse C.E. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep. Veterinary Parasitology 1997, 69:241-253.
7. Alvarez L., Lifschitz A., Entrocasso C., Manazza J., Mottier L., Borda B., Virkel G., Lanusse C. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. Journal of Veterinary Pharmacology and Therapeutics 2008, 31:230-239.
8. Awney H.A., Ghzlan H.E., Sheweita S.A., Mostafa M.H. Different levels of Schistosoma mansoni infection increased the mutagenicity of benzo(a)pyrene, the activity of aryl hydrocarbon hydroxylace and the formation of hepatic microsomal hydrogen peroxide. Toxicology 2001, 163:213-218.
9. Baliharová V., Velík J., Lamka J., Maas R.F., de Vrieze G., Bull S., Fink-Gremmels J. The effect of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with thiabendazole and omeprazole. Journal of Pharmacy and Pharmacology 2003, 55:773-781.
10. Baliharová V., Velík J., Šavlík M., Lamka J., Tahotná J., Szotáková B., Skálová L. The effect of fenbendazole, flubendazole and mebendazole on activities of hepatic cytochromes P450 in pig. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:85-90.
11. Bártíková H., KříŽová V., Lamka J., Kubíček V., Skálová L., Szotáková B. Flubendazole metabolism and biotransformation enzymes activities in healthy sheep and sheep with haemonchosis. Journal of Veterinary Pharmacology and Therapeutics 2009, 33:56-62.
12. Biro-Sauveur B., Eeckhoutte C., Baeza E., Boulard C., Galtier P. Comparison of hepatic and extrahepatic drug-metabolizing enzyme-activities in rats given single or multiple challenge infections with Fasciola hepatica. International Journal for Parasitology 1995, 25:1193-1200.
13. Bruni S.F.S., Jones D.G., Small J., McKellar Q.A. Effects of formulation concentration on intravenous pharmacokinetics, chirality and in vitro solubility of oxfendazole and its metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:467-473.
14. Calléja C., Bigot K., Eeckhoutte C., Sibille P., Boulard C., Galtier P. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica. International Journal for Parasitology 2000, 30:953-958.
15. Capece B.P.S., Castells G., Pérez F., Arboix M., Cristofol C. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep. Veterinary Research Communications 2000, 24:339-348.
16. Capece B.P.S., Afonso S.M.S., Lazáro R., Harun M., Godoy C., Castells G. Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats. Research in Veterinary Science 2009, 86:498-502.
17. Capece B.P.S., Virkel G.L., Lanusse C.E. Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. The Veterinary Journal 2009, 181:241-250.
18. Ceballos L., Moreno L., Alvarez L., Shaw L., Fairweather I., Lanusse C. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes. BMC Veterinary Research 2010, 6.
19. Cristofol C., Franquelo C., Navarro M., Carretero J. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes. Research in Veterinary Science 1997, 62:117-120.
20. Cristofol C., Navarro M., Franquelo M., Valladares J.E., Carretero A., Ruberte J., Arboix M. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity. Toxicology and Applied Pharmacology 1997, 144:56-61.
21. Cristofol C., Navarro M., Franquelo C., Valladares J.E., Arboix M. Sex differences in the disposition of albendazole metabolites in sheep. Veterinary Parasitology 1998, 78:223-231.
22. Debackere M., Landuyt J., Vercruysse J., McKellar Q. The influence of Ostertagia circumcincta and Trichostrongylus colubriformis infections on the pharmacokinetics of febantel in lambs. Journal of Veterinary Pharmacology and Therapeutics 1993, 16:261-274.
23. Delatour P., Benoit E., Lachenet J., Besse S. Pharmacokinetics in sheep and cattle of albendazole administered by an intraruminal slow release capsule. Research in Veterinary Science 1990, 48:271-275.
24. Delatour P., Garnier F., Benoit E., Caude I. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Research in Veterinary Science 1991, 50:134-138.
25. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Enhancement of the drug susceptibility of a triclanbendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole. Parasitology Research 2010, 107:337-353.
26. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Inhibition of cytochrome p450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole. Parasitology 2010, 137:871-880.
27. Evrard B., Chiap P., DeTullio P., Ghalmi F., Piel G., Van Hees T., Crommen J., Losson B., Delattre L. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release 2002, 85:45-50.
28. Facino R.M., Carini M., Genchi C. Decrease in hepatic microsomal UDP-glucuronosyltransferase activity in rats and cattle with fascioliasis: impaired in vitro glucuronidation of oxyclozanide. Toxicology Letters 1985, 26:65-71.
29. Formentini E.A., Mestorino N., Errecalde J.O. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep. Veterinary Research Communications 2005, 29:595-608.
30. Franconi F., Brunelleschi S., Steardo L., Cuomo V. Gender differences in drug responses. Pharmacological Research 2007, 55:81-95.
31. Galtier P., Alvinerie M. Pharmacological basis for hepatic drug metabolism in sheep. Veterinary Research 1996, 27:363-372.
32. Galtier P., Alvinerie M., Plusquellec Y., Tufenkji A.E., Houin G. Decrease in albendazole sulphonation during experimental fascioliasis in sheep. Xenobiotica 1991, 21:917-924.
33. Galtier P., Coulet M., Sutra J.F., Birosauveur B., Alvinerie M. Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. Experimental Parasitology 1994, 79:166-176.
34. García-Llamazares J.L., Merino-Pelaez G., Larrode-Pellicer O., Redondo-Cardeja P.A., Prieto-Fernández J.G., Alvarez-de-Felipe A.I. Pharmacokinetics of netobimin and microsomal metabolism of albendazole in infected gerbils with Echinococcus granulosus. Parasitology Research 2001, 87:107-111.
35. Gibson G.G., Skett P. Introduction to Drug Metabolism 2001, Nelson Thornes Publishers, Cheltenham. third ed.
36. Gokbulut C., Nolan A.M., McKellar Q.A. Pharmacokinetic disposition, foecal excretion and in vitro metabolism of oxibendazole following oral administration in horses. Research in Veterinary Science 2002, 72:11-15.
37. Gokbulut C., Karademir U., Boyacioglu M., Akar F. The effect of diet type on the plasma disposition of triclabendazole in goats. Research in Veterinary Science 2007, 82:388-391.
38. Gokbulut C., Cirak V.Y., Senlik B., Yildirim F., McKellar C.A. Pharmacological assessment of netobimin as a potential anthelmintic for use in horses: plasma disposition, faecal excretion and efficacy. Research in Veterinary Science 2009, 86:514-520.
39. Habib S.L., Sheweita S.A., Awad A.T., Mashaal N.M., Soliman A.A., Mostafa M.H. Influence of Schistosoma mansoni infection on carcinogen-metabolizing capacities and in vitro aflatoxin B-1 metabolism in human liver. Oncology Reports 1996, 3:769-773.
40. Hennessy D.R., Sangster N.C., Steel J.W., Collins G.H. Comparative kinetic disposition of oxfendazole in sheep and goats before and during infection with Haemonchus contortus and Trichostrongylus colubriformis. Journal of Veterinary Pharmacology and Therapeutics 1993, 16:245-253.
41. Jacobs D.E.J., Taylor M.A. Drugs used in the treatment and control of parasitic infections. The Veterinary Formulary 2001, Pharmaceutical Press, London. fifth ed. J. Bishop (Ed.).
42. Jemli M.H., Galtier P., Dorchies P., Benromdhane S., Kilani M. Triclabendazole effect on Fasciola hepatica-induced decrease of biotransformation liver enzymes. Revue de Médecine Veterinaire 1994, 145:349-353.
43. Kaddouri M., Larrieu G., Eeckhoutte C., Galtier P. The development of drug-metabolizing enzymes in female sheep livers. Journal of Veterinary Pharmacology and Therapeutics 1990, 13:340-349.
44. Knox M.R., Steel J.W. Effect of diet and species on the pharmacokinetic of fenbendazole in cattle. Veterinary Research Communications 1997, 21:37-43.
45. Krämer S.D., Testa B. The biochemistry of drug metabolism - an introduction Part 6. Inter-individual factors affecting drug metabolism. Chemistry and Biodiversity 2008, 5:2465-2578.
46. Krämer F., Epe C., Mencke N. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of imidacloprid 10% plus moxidectin 2.5% topical solution to the pregnant dog. Zoonoses Public Health 2009, 56:34-40.
47. KříŽová V., Lamka J., Szotáková B., Vokřál I., Srpová V., Urbánková M., Kubíček V., Nobilis M., Skálová L. Dicrocoeliosis of old mouflon ewes - effect on the biotransformation enzymes and metabolism of anthelmintics in vitro. Open Veterinary Science Journal 2008, 2:23-32.
48. KříŽová V., Nobilis M., PruŠková L., Chládek J., Szotáková B., Cvilink V., Skálová L., Lamka J. Pharmacokinetics of flubendazole and its metabolites in lambs and adult sheep, Ovis aries. Journal of Veterinary Pharmacology and Therapeutics 2009, 32:606-612.
49. Kumar M.P., Rao Y.M., Apte S. Improved bioavailability of albendazole following oral administration of nanosuspension in rats. Current Nanoscience 2007, 3:191-194.
50. Kumar M.P., Rao Y.M., Apte S. Formulation of nanosuspensions of albendazole for oral administration. Current Nanoscience 2008, 4:53-58.
51. Lamka J., KříŽová V., Cvilink V., Šavlík M., Velík J., Ducháček L., Szotáková B., Skálová L. A single adulticide dose of albendazole induces cytochrome P4501A in mouflon, Ovis musimon, with dicrocoeliosis. Veterinary Medicine 2007, 52:343-352.
52. Landuyt J., Debackere M., Vercruysse J., McKellar Q. The influence of a heavy infection with sensitive and resistant strains of Ostertagia circumcincta and with Trichostrongylus colubriformis on the pharmacokinetics of febantel in lambs. Journal of Veterinary Pharmacology and Therapeutics 1995, 18:180-186.
53. Lanusse C.E., Prichard R.K. Pharmacokinetic behaviour of netobimin and its metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 1990, 13:170-178.
54. Lanusse C.E., Prichard R.K. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Veterinary Parasitology 1993, 49:123-158.
55. Lanusse C.E., Nare B., Gascon L.H., Prichard R.K. Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle. Xenobiotica 1992, 22:419-426.
56. Lanusse C.E., Nare B., Prichard R.K. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole. Xenobiotica 1993, 23:285-295.
57. Lanusse C.E., Alvarez L.I., Sallowitz J.M., Mottier M.L., Sanchez Bruni S.F. Antinematodal drugs. Veterinary Pharmacology and Therapeutics 2009, Wiley-Blackwell. ninth ed. J.E. Riviere, M.G. Papich (Eds.).
58. Lifschitz A., Virkel G., Mastromarino M., Lanusse C. Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep. Veterinary Research Communications 1997, 21:201-211.
59. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Lanusse C. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Veterinary Journal 2009, 182:261-268.
60. Machala M., Souček P., Neča J., Ulrich R., Lamka J., Szotáková B., Skálová L. Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Archives of Toxicology 2003, 77:555-560.
61. Manhaes-Rocha D.A., Conte F.P., Fidalgo-Neto A.A., De-Oliveira A.C.A.X., Ribeiro-Pinto L.E., Paumgartten F.J.R. Alterations of hepatic microsomal enzymes in the early phase of murine schistosomiasis. Acta Tropica 2005, 95:58-66.
62. Mathur A.C., Sanyal P.K., Sarkar S. Influence of subclinical nematodosis on the kinetic disposition of fenbendazole in buffaloes. Veterinary Research Communications 1995, 19:49-57.
63. McKellar Q.A., Coop R.L., Jackson F. The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month and eight-month-old sheep. International Journal for Parasitology 1995, 25:1207-1212.
64. McKellar Q.A., Gokbulut C., Muzandu K., Benchaoui J.L. Fenbendazole pharmacokinetics, metabolism and potentiation in horses. Drug Metabolism and Disposition 2002, 30:1230-1239.
65. Merino G., Molina A.J., García J.L., Pulido M.M., Prieto J.G., Alvarez A.I. Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors. International Journal of Pharmaceutics 2003, 263:123-132.
66. Mestorino N., Formentini E.A., Lucas M.F., Fernandez C., Modarnio P., Hernandez E.M., Errecalde J.O. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide. Veterinary Research Communications 2008, 32:21-33.
67. Mirfazaeliana A., Rouinia M.R., Dadashzadehb S. Time dependent pharmacokinetics of albendazole in human. Biopharmaceutics and Drug Disposition 2003, 24:199-204.
68. Molina A.J., Merino G., Prieto J.G., Real R., Mendoza G., Alvarez A.I. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion. European Journal of Pharmaceutical Sciences 2007, 31:16-24.
69. Moroni P., Buronfosse T., Longin-Sauvageon C., Delatour P., Benoit E. Chiral sulfoxidation of albendazole by flavin adenine dinucleotide-containing and cytochromes P450-dependent monooxygenases from rat liver microsomes. Drug Metabolism and Disposition 1995, 23:160-165.
70. Mugford C.A., Kedderis G.L. Sex-dependent metabolism of xenobiotics. Drug Metabolism Reviews 1998, 30:441-498.
71. Mukherjee T., Plakogiannis F.M. Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole. Journal of Pharmacy and Pharmacology 2010, 62:1112-1120.
72. Nebbia C. Biotransformation enzymes as determinants of xenobiotic toxicity in domestic animals. Veterinary Journal 2001, 161:238-252.
73. Nouws J.F. Pharmacokinetic in immature animals: a review. Journal of Animal Science 1992, 70:3627-3634.
74. Oukessou M., Souhaili Z. The effect of feed quality on the kinetic disposition of orally administered triclabendazole in sheep. Veterinary Research Communications 1998, 22:257-263.
75. Pérez R., Palme C., Araneda M., Cabezas I., Rubilar L., Arboix M. Gastrointestinal parasitism reduces the plasma availability of doramectin in lambs. Veterinary Journal 2007, 173:167-173.
76. Renton K.W. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacology and Therapeutics 2001, 92:147-163.
77. Riviere J.E. Comparative Pharmacokinetics 1999, Iowa State Press, Iowa, pp. 21-30.
78. Sánchez S., Alvarez L., Lanusse C. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves. Journal of Veterinary Pharmacology and Therapeutics 1997, 20:38-47.
79. Sánchez S., Alvarez L., Pis A., Quiroga M., Lanusse C. Differences in plasma and abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet. Research in Veterinary Science 1999, 66:223-230.
80. Sánchez S., Alvarez L., Sallovitz J., Lanusse C. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting. Journal of Veterinary Pharmacology and Therapeutics 2000, 23:193-201.
81. Sánchéz-Campos S., Tunón M.J., Gonzáles P., Campo R., Ferreras M.C., Manga Y., Gonzáles-Gallego J. Effects of experimental dicrocoeliosis on oxidative drug metabolism in hamster liver. Comparative Biochemistry and Physiology 1996, 115C:55-60.
82. Sanyal P.K. Kinetic disposition of triclabendazole in buffalo compared to cattle. Journal of Veterinary Pharmacology and Therapeutics 1995, 18:370-374.
83. Sanyal P.K., Gupta S.C. Efficacy and pharmacokinetics of triclabendazole in buffalo with induced fasciolosis. Veterinary Parasitology 1996, 63:75-82.
84. Šavlík M., PoláŠková P., Szotáková B., Lamka J., Skálová L. The effects of flubendazole and mebendazole on hepatic cytochromes P4501A in pheasant. Research in Veterinary Science 2005, 79:139-147.
85. Šavlík M., Fimanová K., Szotáková B., Lamka J., Skálová L. Modulation of swine biotransformation enzymes by anthelmintic therapy with fenbendazole and flubendazole. Research in Veterinary Science 2006, 80:267-274.
86. Šavlík M., Poláčková L., Szotáková B., Lamka J., Velík J., Skálová L. Activities of biotransformation enzymes in pheasant, Phasianus colchicus, and their modulation by in vivo administration of mebendazole and flubendazole. Research in Veterinary Science 2007, 83:20-26.
87. Schwark W.S. Factors that affect drug disposition in food-producing animals during maturation. Journal of Animal Science 1992, 70:3635-3645.
88. Sheweita S.A., Mubark J., Doenhofe M.J. Changes in the expression of cytochrome P450 isoenzymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice. Journal of Helminthology 2002, 76:71-78.
89. Shibuya M., Echizen H., Kubo S., Tamura N., Suzuki K., Ushiama H., Ohnishi A. Reduced urinary 6 beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosis. Hepatology Research 2003, 26:28-33.
90. Skálová L., KříŽová V., Cvilink V., Szotáková B., Štorkánová L., Velík J., Lamka J. Mouflon, Ovis musimon. Dicrocoeliosis: effect of parasitosis on the activities of biotransformation enzymes and albendazole metabolism in liver. Veterinary Parasitology 2007, 146:254-262.
91. Szotáková B., Baliharová V., Lamka J., NoŽinová E., Wsól V., Velík J., Machala M., Neča J., Souček P., Šusová S., Skálová L. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science 2004, 76:43-51.
92. Taylor S.M., Mallon T.R., Blanchflower W.J., Kennedy D.G., Green W.P. Effects of diet on plasma concentrations of oral anthelmintics for cattle and sheep. Veterinary Record 1992, 28:264-268.
93. Taylor S.M., Mallon T.R., Blanchflower W.J., Kennedy D.G., Hewitt S.A. Effects of dietary variations on plasma concentrations of oral flukicides in sheep. Journal of Veterinary Pharmacology and Therapeutics 1993, 16:48-54.
94. Testa B., Caldwell J. The Metabolism of Drugs and other Xenobiotics 1995, Academic Press, London.
95. Van't Klooster G.A.E., Horbach G.J.M.J., Natsuhori M., Blaauboer B.J., Noordhoek J., Van Miert A.S.J.P.A.M. Hepatic cytochrome P450 induction in goats, effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine, and on apoprotein and mRNA levels. Biochemical Pharmacology 1993, 45:113-122.
96. Velík J., Baliharová V., Fink-Gremmels J., Bull S., Lamka J., Skálová L. Benzimidazole drugs and modulation of biotransformation enzymes. Research in Veterinary Science 2004, 76:95-108.
97. Velík J., Baliharová V., Skálová L., Szotáková B., Wsól V., Lamka J. Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:377-384.
98. Velík J., Szotáková B., Baliharová V., Lamka J., Šavlík M., Wsól V., Šnejdrová, Skálová L. Albendazole repeated administration induces cytochromes P4501A and accelerates albendazole deactivation in mouflon, Ovis musimon. Research in Veterinary Science 2005, 78:255-263.
99. Villeneuve J.-P., Pichette V. Cytochrome P450 and liver diseases. Current Drug Metabolism 2004, 5:273-282.
100. Virkel G., Lifschitz A., Pis A., Lanusse C. Influence of diet on the pattern of gastrointestinal biotransformation of netobimin and albendazole sulphoxide in sheep. European Journal of Drug Metabolism and Pharmacokinetics 1999, 24:31-37.
101. Virkel G., Lifschitz A., Sallovitz J., Pis A., Lanusse C.E. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metabolism and Disposition 2004, 32:536-544.
102. Virkel G., Lifschitz A., Sallovitz J., Ballent M., Scarcella S., Lanusse C. Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 2009, 32:79-86.